Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Peritonitis is one of the most important acute complications in peritoneal dialysis patients and one of the most common complications for loss of membrane and technical challenging in renal replacement therapy. Peritoneal dialysis began in 1969 in the former Social Security Hospital, the program currently has 177 patients. The aim of this study is to determine the frequency of and to identify the most common bacteria and antibiogram to be used. Materials and methods: we performed a retrospective epidemiological study from january 2010 to december 2012. We analyzed microorganisms causing peritonitis, antibiotic sensitivity and removal of catheters and peritonitis frequency by gender. Results: the peritoneal dialysis program has 177 patients, 145 in automated peritoneal dialysis (APD), 35 continuous ambulatory peritoneal dialysis (CAPD), 87 patients presented symptoms of peritonitis, 38 women, 49 men, the Gram positive were
the most Frequently, 59 (57.5%), Gram negative 13 (14.9%), fungal infections 3 (3.4%), without developing crops 24 (24.1%). According to the drugs used were ceftazidime 27.59%, vancomycin 24.14%, ciprofloxacin 24.14%, ampicillin 3.45% and fluconazole 3.45%, at 24; 14% of patients had negative cultures and the antibiotic was suspended, six catheters were removed due to Candida albicans infection, 1 with Pseudomonas aeruginosa, 1 with meticilin resistant Staphylococcus aureus, and 1 with recurrent Staphylococcus epidermidis infection. Conclusions: similar to the reported in the literature, in our study Gram positive are the most frequently identified organism.
Schaubel DE, Blake PG,Fenton SA.Trends in CAPD technique failure: Canada, 1981–1997,” Peritnea l Dialysis Int, 2001; 21(4):365–371
Chung SH, Heimburger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean center. Neph Dialysis Transplantation, 2005; 20:1207–1213
Strippoli G,Tong A, Johnson D,Schena FP,Craig JC. Catheterrelated interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrology, 2004; 10:2735–2746
McDonald SP, Collins JF, Rumpsfeld M, Johnson DW. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations,” Perit Dial Int, 2004; 24(4):340–346
Kerschbaum J, Onig K, Rudnicki M. Risk Factors Associated with Peritoneal-Dialysis-Related Peritonitis. Int J Neph, 2012;23:45-48
Szeto CC, Chow KM, Wong TY, Leung CB, WangAY, Luis SF, et al. Feasibility of resuming peritoneal dialysis after severe peritonitis and tenckhoff catheter removal. J Am Soc Nephrol, 2002; 13:1040-5
Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections
recommendations: 2005 update. Perit Dial Int, 2005; 25:107-31
Li PK-T, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, et al. Peritoneal dialysis-related infections recommendations: update. Perit Dial Int, 2010;30:393-423
Pérez-Fontán M, Rodríguez-Carmona A, García-Naveiro R, Rosales M, Villaverde P, Valdés F. Peritonitis-relatedmortality in patientsundergoingchronic peritoneal dialysis. Perit Dial Int, 2005; 25:274-84
Bunke CM, Brier ME, Golper TA. Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int, 1997;52:524-528
Fahim M, Hawley CM, Mc Donald SP, brown FG, Rosman Jb, Wiggins KJ, et al culture - negative peritonitis in peritoneal dialysis patients in Australia: predictors treatment and outcomes in 435 cass. Am J Kidkey Dis, 2010; 55:690-7
Lim DK, Yoo TH, Ryu DR, Choi KH, Lee HY, Han DS, et al. Changes in causative organisms abd their antimicrobial susceptibilities in CAPD peritonitis: a single center’s esperience over one decade. Perit Dial Int, 2004; 24:424-32
Strippoli GF, Tong A, Jonson D, Schena FP, Craig JC. Catéterre lated interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol, 2004; 15:2735-46
Brown F, Liu WJ, Kotsanas D, Korman TM, Atkins RC. A quarter of a century of adult peritoneal dialysis-related peritonitis ar an Australian medical center. Perit Dial Int, 2007; 27:565-74
Lobo JV, Villar KR, Andrade Jr MP, Bastos KA. Predictor factors of peritoneal dialysis-related peritonitis,” J Bras Nefrol, 2010; 32(2):156–164
Han SH, Lee SC, Ahnetal AV. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Neph Dial Transplantation, 2007; 22(9):2653–2658
Wang Q, Bernardini J, Piraino B, Fried L. Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis, 2003; 41(3):664–669
Nessim SJ, Bargman JM, Austin PC, Story K, Jassal SV. Impact of age on peritonitis risk in peritoneal dialysis patients: an era e ect. Clin J Am Soc Neph, 2009; 4(1):135–141
Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV. Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Neph, 2009; 4(7):1195–1200
Lim WH, Johnson DW, Mc Donald SP. Higher rat and earlier peritonitis in Aboriginal patients compared to non Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATA. Neph, 2005; 10(2):192–197
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.